Frastim (filgrastim biosimilar) / RPG Life Sci - LARVOL DELTA

A case of necrotizing stomatitis triggered by postoperative chemotherapy. (JBCS 2026) - "Since December 202X, after confirming the near-complete resolution of necrotizing stomatitis, weekly PTX therapy was introduced and is currently being administered. We have experienced a case of necrotizing stomatitis triggered by postoperative chemotherapy, and we report this case, including a brief literature review and suggested countermeasures."

Clinical • Breast Cancer • Dental Disorders • HER2 Breast Cancer • HER2 Positive Breast Cancer • Hormone Receptor Breast Cancer • Infectious Disease • Solid Tumor • Stomatitis • Thrombocytopenia • ER • HER-2

SAFETY OF HEMATOPOIETIC STEM CELL DONATION. RETROSPECTIVE ANALYSIS OF EARLY POST DONATION FOLLOW UP IN VOLUNTARY DONORS REGISTERED IN DKMS FOUNDATION DONOR CENTER, POLAND (EHA 2019) - "To mobilize the HPC lenogfrastim or filgrastim was used in standard dosage (7-10 µg/kg/day for 4 or 5 consequent days). Abnormalities in the 1FU are mild and mainly refer to CBC, especially in women regardless of the age group. Severe side effects are extremely rare. "

Retrospective data